Christopher D. Ellison

801 total citations
16 papers, 664 citations indexed

About

Christopher D. Ellison is a scholar working on Analytical Chemistry, Pharmaceutical Science and Oncology. According to data from OpenAlex, Christopher D. Ellison has authored 16 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Analytical Chemistry, 6 papers in Pharmaceutical Science and 5 papers in Oncology. Recurrent topics in Christopher D. Ellison's work include Drug Solubulity and Delivery Systems (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Analytical Chemistry and Chromatography (3 papers). Christopher D. Ellison is often cited by papers focused on Drug Solubulity and Delivery Systems (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Analytical Chemistry and Chromatography (3 papers). Christopher D. Ellison collaborates with scholars based in United States and Thailand. Christopher D. Ellison's co-authors include Robbe C. Lyon, Patrick J. Faustino, Mansoor A. Khan, Donna A. Volpe, Lawrence X. Yu, Yongsheng Yang, Ebenezer B. Asafu-Adjaye, Anthony B. Ciavarella, Ajaz Hussain and Bryan J. Ennis and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Christopher D. Ellison

16 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher D. Ellison United States	15	161	154	113	106	98	16	664
Ziqiang Li China	18	49 0.3×	58 0.4×	367 3.2×	86 0.8×	79 0.8×	88	1.1k
Dominic P. Ip United States	17	347 2.2×	62 0.4×	73 0.6×	121 1.1×	72 0.7×	25	741
Peri̇han Ünak Türkiye	16	35 0.2×	41 0.3×	175 1.5×	128 1.2×	91 0.9×	90	895
Adil Mohammad United States	16	67 0.4×	70 0.5×	117 1.0×	8 0.1×	173 1.8×	37	518
Guirag Poochikian United States	9	96 0.6×	148 1.0×	86 0.8×	13 0.1×	264 2.7×	13	598
Mengxiang Su China	18	116 0.7×	15 0.1×	210 1.9×	45 0.4×	173 1.8×	70	751
Abdul Rahman Khan India	20	90 0.6×	20 0.1×	322 2.8×	135 1.3×	224 2.3×	86	1.4k
Fazilet Zümrüt Biber Müftüler Türkiye	15	32 0.2×	42 0.3×	161 1.4×	125 1.2×	71 0.7×	108	840
Karen M. Alsante United States	11	326 2.0×	150 1.0×	184 1.6×	26 0.2×	86 0.9×	12	835
Paola Bertocchi Italy	16	147 0.9×	99 0.6×	136 1.2×	50 0.5×	106 1.1×	34	700

Countries citing papers authored by Christopher D. Ellison

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Ellison more than expected).

Fields of papers citing papers by Christopher D. Ellison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Ellison. The network helps show where Christopher D. Ellison may publish in the future.

Co-authorship network of co-authors of Christopher D. Ellison

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Ellison. A scholar is included among the top collaborators of Christopher D. Ellison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Ellison. Christopher D. Ellison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ellison, Christopher D., et al.. (2016). Bupropion Hydrochloride. PubMed. 41. 1–30. 27 indexed citations

Ellison, Christopher D., et al.. (2012). Use of In Vitro–In Vivo Correlation to Predict the Pharmacokinetics of Several Products Containing a BCS Class 1 Drug in Extended Release Matrices. Pharmaceutical Research. 30(1). 179–190. 17 indexed citations

Nambiar, Sumathi, Rapti D. Madurawe, Saeed R. Khan, et al.. (2012). Product Quality of Parenteral Vancomycin Products in the United States. Antimicrobial Agents and Chemotherapy. 56(6). 2819–2823. 33 indexed citations

Hoag, Stephen W., et al.. (2011). NIR Spectroscopy Applications in the Development of a Compacted Multiparticulate System for Modified Release. AAPS PharmSciTech. 12(1). 262–278. 30 indexed citations

Yang, Yongsheng, Abhay Gupta, Patrick J. Faustino, et al.. (2009). Comparative stability of repackaged metoprolol tartrate tablets. International Journal of Pharmaceutics. 385(1-2). 92–97. 12 indexed citations

Ellison, Christopher D., et al.. (2008). Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging. Journal of Pharmaceutical and Biomedical Analysis. 48(1). 1–7. 53 indexed citations

Volpe, Donna A., et al.. (2008). Effect of Ethanol on Opioid Drug Permeability Through Caco-2 Cell Monolayers. The AAPS Journal. 10(2). 360–362. 18 indexed citations

Faustino, Patrick J., Yongsheng Yang, Charles Brownell, et al.. (2008). Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue. Journal of Pharmaceutical and Biomedical Analysis. 47(1). 114–125. 112 indexed citations

Yang, Yongsheng, Patrick J. Faustino, Donna A. Volpe, et al.. (2007). Biopharmaceutics Classification of Selected β-Blockers: Solubility and Permeability Class Membership. Molecular Pharmaceutics. 4(4). 608–614. 79 indexed citations

10.

Ellison, Christopher D., et al.. (2007). Drug product characterization by Macropixel Analysis of chemical images. Journal of Pharmaceutical Sciences. 96(12). 3390–3401. 34 indexed citations

11.

Volpe, Donna A., Patrick J. Faustino, Anthony B. Ciavarella, et al.. (2007). Classification of Drug Permeability with a Caco-2 Cell Monolayer Assay. Clinical Research and Regulatory Affairs. 24(1). 39–47. 76 indexed citations

12.

Westenberger, Benjamin J., Christopher D. Ellison, Richard E. Kolinski, et al.. (2005). Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. International Journal of Pharmaceutics. 306(1-2). 56–70. 69 indexed citations

13.

Volpe, Donna A., Christopher D. Ellison, Ralph E. Parchment, Charles K. Grieshaber, & Patrick J. Faustino. (2003). Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines. PubMed. 3(4). 169–184. 26 indexed citations

14.

Yu, Lawrence X., Christopher D. Ellison, Dale P. Conner, L J Lesko, & Ajaz Hussain. (2001). Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugs. PubMed. 3(3). 86–92. 16 indexed citations

15.

Yang, Zejia, Patrick J. Faustino, Paul A. Andrews, et al.. (2000). Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemotherapy and Pharmacology. 46(4). 255–262. 39 indexed citations

16.

Weaver, James L., Joseph F. Contrera, Barry A. Rosenzweig, et al.. (1998). An Evaluation of the Hemizygous Transgenic Tg.AC Mouse for Carcinogenicity Testing of Pharmaceuticals. I. Evidence for a Confounding Nonresponder Phenotype. Toxicologic Pathology. 26(4). 532–540. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact